Fetal hematopoietic stem cell transplantation: A challenge for the twenty-first century

Journal of Hematotherapy and Stem Cell Research

Volumn 11, Issue 4, 2002, Pages 617-631

  Shields, Laurence E ^a   Lindton, Bim ^b   Andrews, Robert G ^a,c   Westgren, Magnus ^b  

^a UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^b KAROLINSKA INSTITUTE   (Sweden)

^c Fred Hutchinson Cancer Research Center   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CHIMERA; EXPERIMENTAL MODEL; FETUS; FETUS DEVELOPMENT; FETUS DISEASE; HEMATOPOIETIC STEM CELL TRANSPLANTATION; HUMAN; IMMUNOPATHOLOGY; NONHUMAN; ONTOGENY; PRIORITY JOURNAL; REVIEW; TREATMENT INDICATION;

ANIMALS; FETAL TISSUE TRANSPLANTATION; HEMATOLOGIC DISEASES; HUMANS; IMMUNE SYSTEM DISEASES; METABOLIC DISEASES; MODELS, ANIMAL; STEM CELL TRANSPLANTATION;

EID: 0036323491     PISSN: 15258165     EISSN: None     Source Type: Journal    
DOI: 10.1089/15258160260194767     Document Type: Review

References (95)

1. Engraftment of severe combined immune deficient mice receiving allogeneic bone marrow via In utero or postnatal transfer
2. A case of haemolytic disease with congenital rubella
3. Unmatched stem cell transplantation as a possible alternative to bone marrow transplantation
4. Enzyme replacement therapy - An experiment of nature in chimeric mannosidosis calf
5. Immunogenetic consequences of vascular anastomoses between bovine twins
6. Possible beta-mannosidosis chimera. Altered expression of metabolic perturbations
7. A naturally occurring bone-marrow-chimeric primate. I. Integrity of its immune system
8. The theory of the free-martin
9. Natural bone marrow transplantation in cattle with Pompe's disease
10. Immunological reactivity between chimeric cattle twins. I. Homograft reaction
11. Blood group chimerism in human multiple births is not rare
12. Another example of haemopoietic chimaerism in dizygotic twins
13. Chimeric twins. T.S. and M.R. reexamined
14. Immunological tolerance in an HLA non-identical chimeric twin
15. Equal distribution of congenital blood cell chimerism in dizygotic triplets after in-vitro fertilization
16. A case of twin chimerism
17. MLC and CML studies in the family of a pair of HLA haploidentical chimeric twins
18. Prevention of genetic anemias in mice by microinjection of normal hematopoietic stem cells into the fetal placenta
19. In utero transfer of adult bone marrow cells into recipients with severe combined immunodeficiency disorder yields lymphoid progeny with T- and B-cell functional capabilities
20. Sustained multilineage engraftment of allogeneic hematopoietic stem cells in NOD/SCID mice after in utero transplantation
21. Induction of tolerance in nondefective mice after in utero transplantation of major histocompatibility complex-mismatched fetal hematopoietic stem cells
22. In utero allogeneic hematopoietic stem cell transplantation to induce tolerance
23. In utero engraftment of fully H-2-incompatible versus congenic adult bone marrow transferred into nonanemic or anemic murine fetal recipients
24. In utero bone marrow transplantation induces donor-specific tolerance by a combination of clonal deletion and clonal anergy
25. Transplantation of fetal hematopoietic stem cells in utero: The creation of hematopoietic chimeras
26. Transplantation of hematopoietic stem cells in utero
27. In utero transplantation of hematopoietic stem cells in sheep: The role of T cells in engraftment and graft-versus-host disease
28. In utero hematopoietic stem cell transplantation results in donor specific tolerance and facilitates postnatal "boosting" of donor cell levels
29. Hematopoietic chimerism achieved by in utero hematopoietic stem cell injection does not induce donor-specific tolerance for renal allografts in sheep
30. Hematopoietic cell transplantation in fetal lambs with ceroid-lipofuscinosis
31. Induction of hematopoietic chimerism in the caprine fetus by intraperitoneal injection of fetal liver cells
32. Cell surface antigen expression in early and germ gestation fetal hematopoietic progenitor cells
33. Gene transfer into fetal baboon hematopoietic progenitor cells
34. Gestational age changes in circulating CD34+ hematopoietic stem/progenitor cells in fetal cord blood
35. In-utero transplantation of fetal liver hematopoietic stem cells in monkeys
36. In utero bone marrow transplantation of fetal baboons with mismatched adult baboon marrow
37. On the feasibility of inducing tolerance in man: A study in the cynomolgus monkey
38. Long-term engraftment following in utero T cell-depleted parental marrow transplantation into fetal rhesus monkeys
39. Embryonic and fetal hematopoiesis: An overview
40. Subpopulations of CD34-positive haematopoietic progenitors in fetal blood
41. Expression of CD33, CD38, and HLA-DR on CD34+ human fetal liver progenitors with a high proliferative potential
42. Cotransplantation of human stromal cell progenitors into preimmune fetal sheep results in early appearance of human donor cells in circulation and boosts cell levels in bone marrow at later time points after transplantation
43. Transplantation of fetal cells
44. Evidence of alloreactive T lymphocytes in fetal liver: Implications for fetal hematopoietic stem cell transplantation
45. Development of mitogen responding T cells and natural killer cells in the human fetus
46. Ontogeny of cellular immunity in the human fetus: Development of responses to phytohemagglutinin and to allogeneic cells
47. Fetal blood natural killer cells in human pregnancy
48. The role of natural killer cells in transplantation
49. KDR receptor: A key marker defining hematopoietic stem cells
50. In utero hematopoietic stem cell transplantation. A status report
51. Repetitive bone marrow transplantation in nonmyeloablated recipients
52. In utero engraftment by allogeneic CD34+ marrow cells in nonhuman primates: Relationship to the absolute number of cells transplanted
53. Stem cell transplantation in normal nonmyeloablated host: Relationship between cell dose, schedule, and engraftment
54. Clinical utility in maximizing CD34+ cell count in stem cell grafts
55. In utero stem cell transplantation in non-human primates: The role of T-cell number
56. Engraftment following in utero bone marrow transplantation for globoid cell leukodystrophy
57. Distribution of transplanted fetal stem cells in the human fetus
58. Hematopoietic chimerism in sheep and nonhuman primates by in utero transplantation of fetal hematopoietic stem cells
59. Chimerism and tolerance: From freemartin cattle and neonatal mice to humans
60. Microchimerism and tolerance following intrauterine transplantation and transfusion for alpha-thalassemia-1
61. Intrauterine bone-marrow transplantation at 12 gestation
62. Hematopoietic stem-cell transplantation for the treatment of severe combined immunodeficiency
63. Gene therapy of human severe combined immunodeficiency (SCID)-XI disease
64. Treatment of severe combined immunodeficiency syndrome
65. Effect of aminoglutethimide on murine fetal hepatic erythroid colony formation
66. Steroids and hematopoiesis. I. The effect of steroids on in vitro erythroid colony growth: Structure/activity relationships
67. Effects of dexamethasone on erythroid colony and burst formation from human fetal liver and adult marrow
68. In vitro hematopoiesis is inhibited in humans and non-human primates by recombinant parvo virus capsid
69. Recombinant parvovirus B19 empty capsids inhibit fetal hematopoietic colony formation in vitro
70. Major histocompatibility complex restriction between hematopoietic stem cells and stromal cells in vitro
71. Cotransplantation of stroma results in enhancement of engraftment and early expression of donor hematopoietic stem cells in utero
72. Intravenous injection of apoptotic leukocytes enhances bone marrow engraftment across major histocompatibility barriers
73. Characterization of immunologic tolerance induced by transfusion of UV-B-irradiated allogeneic mononuclear leukocytes
74. Irradiated donor leukocytes promote engraftment of allogeneic bone marrow in major histocompatibility complex mismatched recipients without causing graft-versus-host disease
75. Lack of evidence of permanent engraftment after in utero fetal stem cell transplantation in congenital hemoglobinopathies
76. In utero stem cell therapy
77. Clinical application of intrauterine bone marrow transplantation for treatment of genetic diseases-feasibility studies
78. In utero transplantation of hematopoietic stem cells in humans
79. In utero hematopoietic stem cell transplants for inherited diseases
80. Evidence of induced non-tolerance in HLA-identical twins with hemoglobinopathy after in utero fetal transplantation
81. In utero transplantation of purified stem cells from an HLA identical sibling into a bea-thalassemia embryo
82. In utero stem cell transplantation
83. Attempted bone-marrow transplantation in a 17-week fetus
84. In-utero transplantation of parental CD34 haematopoietic progenitor cells in a patient with X-linked severe combined immunodeficiency (SCIDXI)
85. Treatment of X-linked severe combined immunodeficiency by in utero transplantation of paternal bone marrow
86. In utero transplantation (IUT) of parental CD34+ cells in patient affected by primary immunodeficiencies
87. Prenatal T cell reconstruction after in utero transplantation with fetal liver cells in a transplantation with x-linked SCID
88. Transplantation of hematopoietic cells from the fetal liver to treat patients with congenital diseases postnatally or prenatally
89. Transplantation of a fetus with paternal Thy-l(+)CD34(+)cells for chronic granulomatous disease
90. In utero hematopoietic stem cell transplantation: Ontogenic opportunities and biologic barriers
91. Prenatal transplant in a fetus affected by Omenn syndrome
92. A human-murine chimera model for in utero human hematopoietic stem cell transplantation
93. Blood chimeric twins: An example of blood cell chimerism